Education
About Us
Working with TipRanks
Follow Us
Nuvation Bio (NUVB)
NYSE:NUVB
Total Valuation
Nuvation Bio has a market cap or net worth of $632.89M. The enterprise value is $319.27M.
Market Cap$632.89M
Enterprise Value$319.27M
Share Statistics
Nuvation Bio has 339,262,970 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding339,262,970
Owned by Insiders27.05%
Owned by Institutions22.72%
Financial Efficiency
Nuvation Bio’s return on equity (ROE) is -1.22 and return on invested capital (ROIC) is -120.86%.
Return on Equity (ROE)-1.22
Return on Assets (ROA)-1.05
Return on Invested Capital (ROIC)-120.86%
Return on Capital Employed (ROCE)-1.23
Revenue Per Employee28.84K
Profits Per Employee-2.08M
Employee Count273
Asset Turnover0.01
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Nuvation Bio is -1.26. Nuvation Bio’s PEG ratio is -1.88.
PE Ratio-1.26
PS Ratio0.00
PB Ratio0.64
Price to Fair Value1.54
Price to FCF-4.31
Price to Operating Cash Flow-4.33
PEG Ratio-1.88
Income Statement
In the last 12 months, Nuvation Bio had revenue of 7.87M and earned -567.94M in profits. Earnings per share was -2.11.
Revenue7.87M
Gross Profit795.00K
Operating Income-592.63M
Pretax Income-567.94M
Net Income-567.94M
EBITDA-566.91M
Earnings Per Share (EPS)-2.11
Cash Flow
In the last 12 months, operating cash flow was -114.71M and capital expenditures -135.00K, giving a free cash flow of -114.85M billion.
Operating Cash Flow-114.71M
Free Cash Flow-114.85M
Free Cash Flow per Share-0.34
Dividends & Yields
Nuvation Bio pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2.07
52-Week Price Change-43.56%
50-Day Moving Average2.13
200-Day Moving Average2.39
Relative Strength Index (RSI)34.73
Average Volume (3m)5.78M
Important Dates
Nuvation Bio upcoming earnings date is Aug 6, 2025, TBA Not Confirmed.
Last Earnings DateMay 7, 2025
Next Earnings DateAug 6, 2025
Ex-Dividend Date―
Financial Position
Nuvation Bio as a current ratio of 9.04, with Debt / Equity ratio of 0.65%
Current Ratio9.04
Quick Ratio9.04
Debt to Market Cap0.01
Net Debt to EBITDA0.05
Interest Coverage Ratio-1.74K
Taxes
In the past 12 months, Nuvation Bio has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Nuvation Bio EV to EBITDA ratio is -1.21, with an EV/FCF ratio of -5.27.
EV to Sales87.40
EV to EBITDA-1.21
EV to Free Cash Flow-5.27
EV to Operating Cash Flow-5.28
Balance Sheet
Nuvation Bio has $461.68M in cash and marketable securities with $11.41M in debt, giving a net cash position of -$450.26M billion.
Cash & Marketable Securities$461.68M
Total Debt$11.41M
Net Cash-$450.26M
Net Cash Per Share-$1.33
Tangible Book Value Per Share$1.71
Margins
Gross margin is 0.00%, with operating margin of -7527.33%, and net profit margin of -7213.76%.
Gross Margin0.00%
Operating Margin-7527.33%
Pretax Margin-7213.76%
Net Profit Margin-7213.76%
EBITDA Margin-7200.75%
EBIT Margin-7209.42%
Analyst Forecast
The average price target for Nuvation Bio is $7.40, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$7.40
Price Target Upside332.75% Upside
Analyst ConsensusStrong Buy
Analyst Count6
Revenue Growth Forecast―
EPS Growth Forecast-551.08%